Experimental Drug for Bietti’s Crystalline Dystrophy Gets Orphan Drug Designation
Hans / Pixabay

Experimental Drug for Bietti’s Crystalline Dystrophy Gets Orphan Drug Designation

According to a story from BioSpace, the gene therapy company Reflection Biotechnologies Ltd. recently announced that the US Food and Drug Administration (FDA) has given Orphan Drug designation to its…

Continue Reading Experimental Drug for Bietti’s Crystalline Dystrophy Gets Orphan Drug Designation

First Chemotherapy-Free Combination Treatment Approved For Waldrenstrom’s Macroglobulinemia

According to a story from BioSpace, the biopharmaceutical company AbbVie recently announced that the US Food and Drug Administration (FDA) has approved a new combination treatment for Waldenstrom's macroglobulinemia (WM).…

Continue Reading First Chemotherapy-Free Combination Treatment Approved For Waldrenstrom’s Macroglobulinemia
Investigational Gene Therapy for Hereditary Angioedema Gets Orphan Drug Designation
qimono / Pixabay

Investigational Gene Therapy for Hereditary Angioedema Gets Orphan Drug Designation

According to a story from globnewswire.com, the gene therapy company Adverum Biotechnologies recently announced that the US Food and Drug Administration (FDA) has granted them Orphan Drug designation for their…

Continue Reading Investigational Gene Therapy for Hereditary Angioedema Gets Orphan Drug Designation
Hepatocellular Carcinoma Patient’s Twin Sister is Fundraising for £80,000 Treatment
nattanan23 / Pixabay

Hepatocellular Carcinoma Patient’s Twin Sister is Fundraising for £80,000 Treatment

According to a story from the St. Helens Star, Amanda Sackville-Wiggins was diagnosed with hepatocellular carcinoma, a rare type of liver cancer, just after her 21st birthday. The cancer was…

Continue Reading Hepatocellular Carcinoma Patient’s Twin Sister is Fundraising for £80,000 Treatment